---
title: "Propranolol - Cardiomyopathy, Hypertrophic"
sidebar: mydoc_sidebar
permalink: db00571-mesh-d002312-1.html
toc: false 
---


Path ID: `DB00571_MESH_D002312_1`
{% include image.html url="images/db00571-mesh-d002312-1.png" file="db00571-mesh-d002312-1.png" alt="db00571-mesh-d002312-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D011433">MESH:D011433 </a> | Propranolol | Drug |
| <a href="https://identifiers.org/UniProt:P08588">UniProt:P08588 </a> | Beta-1 adrenergic receptor | Protein |
| <a href="https://identifiers.org/UniProt:P07550">UniProt:P07550 </a> | Beta-2 adrenergic receptor | Protein |
| <a href="https://identifiers.org/MESH:D004837">MESH:D004837 </a> | Epinephrine | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D009638">MESH:D009638 </a> | Norepinephrine | ChemicalSubstance |
| <a href="https://identifiers.org/HP:0000822">HP:0000822 </a> | Hypertension | PhenotypicFeature |
| <a href="https://identifiers.org/HP:0001714">HP:0001714 </a> | Ventricular hypertrophy | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D002312">MESH:D002312 </a> | Cardiomyopathy, Hypertrophic | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Propranolol | DECREASES ACTIVITY OF | Beta-1 Adrenergic Receptor |
| Propranolol | DECREASES ACTIVITY OF | Beta-2 Adrenergic Receptor |
| Beta-1 Adrenergic Receptor | POSITIVELY CORRELATED WITH | Epinephrine |
| Beta-1 Adrenergic Receptor | POSITIVELY CORRELATED WITH | Norepinephrine |
| Beta-2 Adrenergic Receptor | POSITIVELY CORRELATED WITH | Epinephrine |
| Beta-2 Adrenergic Receptor | POSITIVELY CORRELATED WITH | Norepinephrine |
| Epinephrine | POSITIVELY CORRELATED WITH | Hypertension |
| Norepinephrine | POSITIVELY CORRELATED WITH | Hypertension |
| Hypertension | CONTRIBUTES TO | Ventricular Hypertrophy |
| Ventricular Hypertrophy | MANIFESTATION OF | Cardiomyopathy, Hypertrophic |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00571#mechanism-of-action](https://go.drugbank.com/drugs/DB00571#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Propranolol#Pharmacology](https://en.wikipedia.org/wiki/Propranolol#Pharmacology)
  - [https://www.uniprot.org/uniprot/P08588#function](https://www.uniprot.org/uniprot/P08588#function)
  - [https://www.uniprot.org/uniprot/P07550#function](https://www.uniprot.org/uniprot/P07550#function)
  - [https://www.sciencedirect.com/science/article/pii/S0735109701014334](https://www.sciencedirect.com/science/article/pii/S0735109701014334)
  - [https://en.wikipedia.org/wiki/Hypertrophic_cardiomyopathy](https://en.wikipedia.org/wiki/Hypertrophic_cardiomyopathy)
